There are currently two prominent experimental treatments against Corona: This is an antibody treatment developed by Eli Lilly, as well as the Regeneron treatment, and these two drugs are undergoing testing in various parts of the country. United State.
Initial results reveal that these two treatments help to decrease the level Virus In the body, as well as reducing the days that the patient stays in the hospital, if this treatment is provided during the first stage of the disease.
On Friday, a spokeswoman for “Eli Lilly” refused to make a statement about whether the company had received a request to provide treatment to Trump, who the White House indicated that he had only mild symptoms.
McCauley confirmed that she could not answer this question, and did not clarify whether the company had previously provided the drug to people who did not participate in clinical trials.
For its part, a spokeswoman for “Regeneron”, Hala Mirza, said that the company does not disclose the names of people who asked to participate in the trials or did not, without their consent.
She added that the company’s top priority is to ensure adequate doses for the procedure Clinical trials.
The official indicated that there is a limited amount of doses that can be given based on some requests, in exceptional circumstances, and after studying each case separately.
And when the White House chief of staff, Mark Meadows, was asked whether Trump would take a treatment.Hydroxychloroquine“The malaria profile, he said he would not talk about aspects of providing medical care to the president of the United States.
Meadows assured that he will not go into details of the treatment the president will receive after confirming his infection with the emerging coronavirus.
In the meantime, “The New York Times” talked about a years-long friendship between Trump and CEO of “Regeneron”, Leonard Schleifer, and this proximity may be a factor of fortune for the US President.
The American academic was a member of Trump’s “golf club” in West Chester County New York StateBut he refused to answer questions about a treatment for Trump.
In the same vein, there is another relationship between the Trump administration and the “Eli Lilly” company, because Alex Azar, the US Secretary of Health and Human Services, was assuming executive responsibility in the company earlier.
But the US Food and Drug Administration has not approved the emergency use of the drug so far, and in this case, the drug can only be provided to the patient in one case known as “merciful use,” meaning that the patient is in critical condition despite trying all other treatment options, and because he may depart Life is inevitable if he does not benefit from the drug, which is still in the experiment phase.